Metabolic Remodeling Induced by Mitochondrial Aldehyde Stress Stimulates Tolerance to Oxidative Stress in the Heart

Rationale: Aldehyde accumulation is regarded as a pathognomonic feature of oxidative stress–associated cardiovascular disease. Objective: We investigated how the heart compensates for the accelerated accumulation of aldehydes. Methods and Results: Aldehyde dehydrogenase 2 (ALDH2) has a major role in aldehyde detoxification in the mitochondria, a major source of aldehydes. Transgenic (Tg) mice carrying an Aldh2 gene with a single nucleotide polymorphism (Aldh2*2) were developed. This polymorphism has a dominant-negative effect and the Tg mice exhibited impaired ALDH activity against a broad range of aldehydes. Despite a shift toward the oxidative state in mitochondrial matrices, Aldh2*2 Tg hearts displayed normal left ventricular function by echocardiography and, because of metabolic remodeling, an unexpected tolerance to oxidative stress induced by ischemia/reperfusion injury. Mitochondrial aldehyde stress stimulated eukaryotic translation initiation factor 2&agr; phosphorylation. Subsequent translational and transcriptional activation of activating transcription factor-4 promoted the expression of enzymes involved in amino acid biosynthesis and transport, ultimately providing precursor amino acids for glutathione biosynthesis. Intracellular glutathione levels were increased 1.37-fold in Aldh2*2 Tg hearts compared with wild-type controls. Heterozygous knockout of Atf4 blunted the increase in intracellular glutathione levels in Aldh2*2 Tg hearts, thereby attenuating the oxidative stress–resistant phenotype. Furthermore, glycolysis and NADPH generation via the pentose phosphate pathway were activated in Aldh2*2 Tg hearts. (NADPH is required for the recycling of oxidized glutathione.) Conclusions: The findings of the present study indicate that mitochondrial aldehyde stress in the heart induces metabolic remodeling, leading to activation of the glutathione–redox cycle, which confers resistance against acute oxidative stress induced by ischemia/reperfusion.

[1]  G. Heusch,et al.  Loss of cardioprotection with ageing. , 2009, Cardiovascular research.

[2]  Lydia W. S. Finley,et al.  The coordination of nuclear and mitochondrial communication during aging and calorie restriction , 2009, Ageing Research Reviews.

[3]  M. Murata,et al.  Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. , 2009, The Journal of clinical investigation.

[4]  Shelly C. Lu.  Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.

[5]  M. Disatnik,et al.  Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. , 2009, Journal of molecular and cellular cardiology.

[6]  K. Fukuda,et al.  Activation of mitochondrial biogenesis by hormesis. , 2008, Circulation research.

[7]  G. Heusch,et al.  Cardioprotection: nitric oxide, protein kinases, and mitochondria. , 2008, Circulation.

[8]  M. Disatnik,et al.  Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart , 2008, Science.

[9]  K. Nishimaki,et al.  Age-Dependent Neurodegeneration Accompanying Memory Loss in Transgenic Mice Defective in Mitochondrial Aldehyde Dehydrogenase 2 Activity , 2008, The Journal of Neuroscience.

[10]  P. Gout,et al.  The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases , 2008, Journal of cellular physiology.

[11]  Linda Partridge,et al.  Minireview Stress-response Hormesis and Aging: ''that Which Does Not Kill Us Makes Us Stronger'' Figure 1. Dose-response Curve of a Treatment with a Hormetic Effect Minireview Cell Metabolism , 2022 .

[12]  K. Ramaiah,et al.  Reduced eIF2α phosphorylation and increased proapoptotic proteins in aging , 2007 .

[13]  Y. Oshida,et al.  CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations. , 2007, Mitochondrion.

[14]  D. Conklin,et al.  Aldehyde metabolism in the cardiovascular system. , 2007, Molecular bioSystems.

[15]  K. Ramaiah,et al.  Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. , 2007, Biochemical and biophysical research communications.

[16]  S. Yuasa,et al.  Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. , 2007, The Journal of biological chemistry.

[17]  R. A. Butow,et al.  Mitochondrial retrograde signaling. , 2006, Annual review of genetics.

[18]  T. Anthony,et al.  Coping with stress: eIF2 kinases and translational control. , 2006, Biochemical Society transactions.

[19]  K. Kitagawa,et al.  Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity shows high acetaldehyde level in blood, brain, and liver after ethanol gavages. , 2005, Alcoholism, clinical and experimental research.

[20]  Hong Chen,et al.  Nutritional control of gene expression: how mammalian cells respond to amino acid limitation. , 2005, Annual review of nutrition.

[21]  Vasilis Vasiliou,et al.  Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family , 2005, Human Genomics.

[22]  M. Koenig,et al.  Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.

[23]  R. Tsien,et al.  Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.

[24]  S. Ohta,et al.  Mitochondrial ALDH2 Deficiency as an Oxidative Stress , 2004, Annals of the New York Academy of Sciences.

[25]  V. Vasiliou,et al.  Role of Human Aldehyde Dehydrogenases in Endobiotic and Xenobiotic Metabolism , 2004, Drug metabolism reviews.

[26]  V. Vasiliou,et al.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. , 2003, The Biochemical journal.

[27]  A. Raina,et al.  Hydroxynonenal, toxic carbonyls, and Alzheimer disease. , 2003, Molecular aspects of medicine.

[28]  S. Ohta,et al.  Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females , 2003, Journal of Human Genetics.

[29]  R. Kaufman,et al.  All roads lead to ATF4. , 2003, Developmental cell.

[30]  K. Nishimaki,et al.  Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells , 2003, Journal of neurochemistry.

[31]  H. Hammes,et al.  Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.

[32]  R. Paules,et al.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.

[33]  Y. Awasthi,et al.  Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. , 2003, Acta biochimica Polonica.

[34]  F. Netter,et al.  Supplemental References , 2002, We Came Naked and Barefoot.

[35]  C. Des Rosiers,et al.  Quantitative gas chromatographic-mass spectrometric assay of 4-hydroxynonenal bound to thiol proteins in ischemic/reperfused rat hearts. , 2002, Free radical biology & medicine.

[36]  K. Kitagawa,et al.  Diminished alcohol preference in transgenic mice lacking aldehyde dehydrogenase activity. , 2002, Pharmacogenetics.

[37]  A. Giordano,et al.  Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy , 2002, Nature Medicine.

[38]  Hongqiao Zhang,et al.  4-hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. , 2002, Free radical biology & medicine.

[39]  Masaru Tomita,et al.  Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. , 2002, Analytical chemistry.

[40]  J. Downey,et al.  Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. , 2001, Journal of the American College of Cardiology.

[41]  M. Imagawa,et al.  Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. , 2000, Biochemical and biophysical research communications.

[42]  T. Soga,et al.  Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. , 2000, Analytical chemistry.

[43]  J. Manson,et al.  Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. , 2000, Journal of the American College of Cardiology.

[44]  E J Calabrese,et al.  Hormesis: A Highly Generalizable and Reproducible Phenomenon With Important Implications for Risk Assessment , 1999, Risk analysis : an official publication of the Society for Risk Analysis.

[45]  Yoshimasa Nakamura,et al.  Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation , 1999, The Journal of Biological Chemistry.

[46]  S. Akira,et al.  Targeted disruption of ATF4 discloses its essential role in the formation of eye lens fibres , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[47]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[48]  C. G. Steinmetz,et al.  Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. , 1997, Structure.

[49]  E. Stadtman,et al.  Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[50]  N Enomoto,et al.  Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. , 1991, Alcoholism, clinical and experimental research.

[51]  M. Tsan,et al.  Relation between myocardial glutathione content and extent of ischemia-reperfusion injury. , 1989, Circulation.

[52]  A. Meister,et al.  Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. , 1984, The Journal of biological chemistry.